Concepedia

Lee Funk

LF

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2001

Affiliations

Pfizer (United States)(Current)

Duquesne University

Lee Funk is an author at Pfizer (United States) specializing in medicinal chemistry, drug design, and drug discovery.

Publications per year

2001–2011

6

Publications

6

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

J. Jean Cui, Michelle Tran‐Dubé, Hong Shen et al. · Journal of Medicinal Chemistry · 2011 · 922 citations · Full text

, , +17

Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone

Pei‐Pei Kung, Lee Funk, Jerry Meng et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · Full text

, , +11

Deprotecting Dithiane-Containing Alkaloids

Fraser F. Fleming, Lee Funk, Ramazan Altundaş et al. · The Journal of Organic Chemistry · 2001 · 41 citations

, , +6

Inhibitors of HCV NS5B polymerase. Part 2: Evaluation of the northern region of (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid

Jeffrey A. Pfefferkorn, Richard A. Nugent, Rebecca J. Gross et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 33 citations

, , +14

Cyclic Alkenenitriles:  Chemoselective Oxonitrile Cyclizations

Fraser F. Fleming, Lee Funk, Ramazan Altundaş et al. · The Journal of Organic Chemistry · 2002 · 24 citations

, , +10

1–5 of 6